International audienceGene mutations causing cytoplasmic mislocalization of the RNA-binding protein FUS lead to severe forms of amyotrophic lateral sclerosis (ALS). Cytoplasmic accumulation of FUS is also observed in other diseases, with unknown consequences. Here, we show that cytoplasmic mislocalization of FUS drives behavioral abnormalities in knock-in mice, including locomotor hyperactivity and alterations in social interactions, in the absence of widespread neuronal loss. Mechanistically, we identified a progressive increase in neuronal activity in the frontal cortex of Fus knock-in mice in vivo, associated with altered synaptic gene expression. Synaptic ultrastructural and morphological defects were more pronounced in inhibitory than ...
Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are relentlessly pr...
Mutations to the RNA binding protein, fused in sarcoma (FUS) occur in ∼5% of familial ALS and FUS-po...
Variants in the ubiquitously expressed DNA/RNA-binding protein FUS cause aggressive juvenile forms o...
International audienceGene mutations causing cytoplasmic mislocalization of the RNA-binding protein ...
Gene mutations causing cytoplasmic mislocalization of the RNA-binding protein FUS, lead to severe fo...
International audienceFUS is an RNA-binding protein involved in amyotrophic lateral sclerosis (ALS) ...
International audienceMutations disrupting the nuclear localization of the RNA-binding protein FUS c...
FUS is a primarily nuclear RNA-binding protein with important roles in RNA processing and transport....
The RNA-binding protein fused-in-sarcoma (FUS) has been associated with amyotrophic lateral sclerosi...
Cytoplasmic aggregation of fused in sarcoma (FUS) is detected in brain regions affected by amyotroph...
Summary Through the generation of humanized FUS mice expressing full-length human FUS, we identify t...
Through the generation of humanized FUS mice expressing full-length human FUS, we identify that when...
Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are relentlessly pr...
Mutations to the RNA binding protein, fused in sarcoma (FUS) occur in ∼5% of familial ALS and FUS-po...
Variants in the ubiquitously expressed DNA/RNA-binding protein FUS cause aggressive juvenile forms o...
International audienceGene mutations causing cytoplasmic mislocalization of the RNA-binding protein ...
Gene mutations causing cytoplasmic mislocalization of the RNA-binding protein FUS, lead to severe fo...
International audienceFUS is an RNA-binding protein involved in amyotrophic lateral sclerosis (ALS) ...
International audienceMutations disrupting the nuclear localization of the RNA-binding protein FUS c...
FUS is a primarily nuclear RNA-binding protein with important roles in RNA processing and transport....
The RNA-binding protein fused-in-sarcoma (FUS) has been associated with amyotrophic lateral sclerosi...
Cytoplasmic aggregation of fused in sarcoma (FUS) is detected in brain regions affected by amyotroph...
Summary Through the generation of humanized FUS mice expressing full-length human FUS, we identify t...
Through the generation of humanized FUS mice expressing full-length human FUS, we identify that when...
Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are relentlessly pr...
Mutations to the RNA binding protein, fused in sarcoma (FUS) occur in ∼5% of familial ALS and FUS-po...
Variants in the ubiquitously expressed DNA/RNA-binding protein FUS cause aggressive juvenile forms o...